Redcloudbio

自由容器

Create Medicines With Unprecedented Precision

For Healthier Life.

RedCloud Bio focuses on novel targets or known targets with drug resistance, integrating structural pharmacology and computational technologies, to discover and develop breakthrough therapeutics for patients with cancer and other severe diseases of high unmet needs.

﹀

自由容器

An Innovative,

Proprietary Discovery And Development Platform

RedCloud Bio has established a robust small molecule drug discovery engine based on experimental structural pharmacology and enhanced by molecular dynamics simulations, computational chemistry and artificial intelligence, and a dedicated and experienced preclinical and clinical development team. Focusing on new and known drug targets with high unmet medical needs…

More Info

自由容器-副本1

Breakthrough Technologies In Structural Pharmacology

Our structural pharmacology approach enables us to gain precise, detailed insights into molecular structures and mechanisms of action of critical mutations – a crucial step for rational design and advancement of new drugs. RedCloud Bio has integrated ultra-high-throughput virtual screening (UHTVS) algorithms and molecular dynamics/ computational chemistry-aided compound optimization to facilitate discovery and development of novel small molecule drugs with specificity and efficiency.

More Info

自由容器-副本1-副本1

Innovative Discovery And

Clinical Pipeline

RedCloud Bio has accumulated structural data and algorithm models covering clinically important targets, and has built an innovative pipeline targeting tumor resistance, rare and other critical diseases with high unmet medical needs, using its core technology platform.

More Info

The Company’s lead therapeutic candidate, H002, is a small molecule compound addressing EGFR activating mutations, and is expected to enter global clinical trials. The compound is a promising candidate as a next-generation TKI with unique clinical differentiation for NSCLC.

自由容器-副本1-副本2

Competitive Research And Development Teams

RedCloud Bio has built laboratories in Shanghai and Beijing, with discovery and development teams covering structural pharmacology, computational technologies, medicinal chemistry and biology as well as disciplines related to preclinical and clinical development and chemistry, manufacturing and controls.

More Info

自由容器